Reducing Alzheimer’s Disease Risk in Diabetes: Synergistic Effects of Metformin, GLP-1 Receptor Agonists, and SGLT2 Inhibitors
Year: 2025
Type: preprint
Study design: Observational Study
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.5502026
Authors: Miski Abdi, Suravi Bajaj, Wei Tse Li, Daniel J. John, Katherine Bangen, Michael Hogarth, Jessica Wang-Rodriguez, Weg M. Ongkeko
Institution: University of California San Diego
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4414373344
Cites:
Cited by:
Related to: